Trials / Completed
CompletedNCT01500486
Observational Study of Norditropin NordiFlex® With NordiFlex PenMate™
Observational Study to Assess Ease of Use, Acceptability and Preference of Norditropin NordiFlex® With NordiFlex PenMate™ in Subjects on Prescribed Growth Hormone Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 84 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is conducted in Europe. The aim of this study is to evaluate ease of injection of growth hormone in patients using Norditropin NordiFlex® with NordiFlex PenMate™. Convenience and tolerability of NordiFlex PenMate™ - an automatic injection and a needle hiding device - is also evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NordiFlex PenMate™ | Subjects whom will be offered growth hormone (Norditropin NordiFlex®) on prescription as part of normal clinical practice will be asked to evaluate the NordiFlex PenMate™ device. |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2011-12-28
- Last updated
- 2016-11-17
Locations
4 sites across 3 countries: Germany, Netherlands, Sweden
Source: ClinicalTrials.gov record NCT01500486. Inclusion in this directory is not an endorsement.